Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 68, Issue 6, 2009, Pages 1036-1043

  Van Lieshout, A W T ^a   Van Der Voort, R ^a   Toonen, L W J ^a   Van Helden, S F G ^a   Figdor, C G ^a   Van Riel, P L C M ^a   Radstake, T R D J ^a   Adema, G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CXCL16 CHEMOKINE; LIPOPOLYSACCHARIDE; RECOMBINANT ANTIBODY; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 4;

ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; CELL CULTURE; CELL ISOLATION; CELL SECRETION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TH1 CELL; UPREGULATION;

ANTIGENS, CD14; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CHEMOKINES, CXC; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MACROPHAGES; MYELOID CELLS; RECEPTORS, SCAVENGER; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TH1 CELLS; TH2 CELLS;

EID: 67449119687     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2007.086611     Document Type: Article

References (43)

1. Thomas R. Antigen-presenting cells in rheumatoid arthritis. Springer Semin Immunopathol 1998;20:53-72. (Pubitemid 28502449)
2. Weyand CM, Braun A, Takemura S, Goronzy JJ. Lymphoid microstructures in rheumatoid synovitis. Curr Dir Autoimmun 2001;3:168-187
3. Weyand CM, Goronzy JJ. Ectopic germinal center formation in rheumatoid synovitis. Ann N Y Acad Sci 2003;987:140-149 (Pubitemid 36584016)
4. Thomas R, McIlraith M, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum 1992;35:1455-1465 (Pubitemid 23013653)
5. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002;168:5333-5341 (Pubitemid 34496002)
6. Radstake TR, Blom AB, Sloetjes AW, van Gorselen EO, Pesman GJ, Engelen L, et al. Increased FccRII expression and aberrant tumour necrosis factor a production by mature dendritic cells from patients with active rheumatoid arthritis. Ann Rheum Dis 2004;63:1556-1563 (Pubitemid 39573681)
7. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994;152:2613-2623 (Pubitemid 24097956)
8. Radstake TR, Van DV, ten Brummelhuis M, De Waal MM, Schreurs W, Looman M, et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis and regulation by Fc gamma receptors. Ann Rheum Dis 2005;64:359-367
9. Radstake TR, van Lent PL, Pesman GJ, Blom AB, Sweep FG, Ronnelid J, et al. High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FccR triggering. Ann Rheum Dis 2004;63:696-702. (Pubitemid 38658400)
10. Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003;349:1907-1915 (Pubitemid 37409707)
11. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000;1:298-304.
12. van der Voort R, van Lieshout AW, Toonen LW, Sloetjes AW, van Den Berg WB, Figdor CG, et al. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum 2005;52:1381-1391 (Pubitemid 40663928)
13. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 2003;170:1136-1140 (Pubitemid 36139476)
14. Jiang X, Shimaoka T, Kojo S, Harada M, Watarai H, Wakao H, et al. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 2005;175:2051-2055 (Pubitemid 41113808)
15. Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK III, et al. CXCL16- mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 2006;54:765-778
16. Tabata S, Kadowaki N, Kitawaki T, Shimaoka T, Yonehara S, Yoshie O, et al. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+T cells. J Leukoc Biol 2005;77:777-786 (Pubitemid 40628758)
17. Wuttge DM, Zhou X, Sheikine Y, Wagsater D, Stemme V, Hedin U, et al. CXCL16/ SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004;24:750-755 (Pubitemid 38451615)
18. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 2004;172:6362-6372 (Pubitemid 38621245)
19. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 2004;172:3678-3685 (Pubitemid 38337951)
20. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, Kita T, et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000;275:40663-40666 (Pubitemid 32054881)
21. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, et al. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 2004;75:267-274 (Pubitemid 38174584)
22. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, et al. Bonzo/ CXCR6 expression defines type 1-polarized T-cell subsets with extra-lymphoid tissue homing potential. J Clin Invest 2001;107:595-601. (Pubitemid 32205180)
23. Agostini C, Cabrelle A, Calabrese F, Bortoli M, Scquizzato E, Carraro S, et al. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med 2005;172:1290-1298 (Pubitemid 43076568)
24. Morgan AJ, Guillen C, Symon FA, Huynh TT, Berry MA, Entwisle JJ, et al. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy 2005;35:1572-1580 (Pubitemid 43919792)
25. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2005;52:3004-3014 (Pubitemid 41447079)
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
27. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van De Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-48
28. van Lieshout AW, Barrera P, Smeets RL, Pesman GJ, van Riel PL, van Den Berg WB, et al. Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis. Ann Rheum Dis 2005;64:408-414 (Pubitemid 40283051)
29. van Lieshout AW, van der Voort R, le Blanc LM, Roelofs MF, Schreurs BW, van Riel PL, et al. Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, Toll-like receptors and rheumatoid synovial fluid. BMC Immunol 2006;7:23.
30. van Lieshout AW, Fransen J, Flendrie M, Eijsbouts AM, van den Hoogen FH, van Riel PL, et al. Circulating levels of the chemokine CCL18, but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis. Ann Rheum Dis 2007;66:1334-1338 (Pubitemid 47492477)
31. Vissers JL, Hartgers FC, Lindhout E, Teunissen MB, Figdor CG, Adema GJ. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J Leukoc Biol 2001;69:785-793 (Pubitemid 32466418)
32. Mohamadzadeh M, Berard F, Essert G, Chalouni C, Pulendran B, Davoust J, et al. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med 2001;194:1013-1020 (Pubitemid 32953269)
33. Mohty M, Vialle-Castellano A, Nunes JA, Isnardon D, Olive D, Gaugler B. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J Immunol 2003;171:3385-3393 (Pubitemid 37254538)
34. Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J, et al. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 2005;52:2686-2692 (Pubitemid 41369096)
35. Wong T, Majchrzak B, Bogoch E, Keystone EC, Fish EN. Therapeutic implications for interferon-alpha in arthritis: a pilot study. J Rheumatol 2003;30:934-940 (Pubitemid 36529610)
36. Coccia EM, Del RN, Stellacci E, Testa U, Marziali G, Battistini A. STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules. Int Immunol 1999;11:1075-1083 (Pubitemid 29338749)
37. Gessani S, Testa U, Varano B, Di MP, Borghi P, Conti L, et al. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors. J Immunol 1993;151:3758-3766 (Pubitemid 23282688)
38. Heydtmann M, Lalor PF, Eksteen JA, Hubscher SG, Briskin M, Adams DH. CXC Chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol 2005;174:1055-1062 (Pubitemid 40094302)
39. Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, et al. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 1995;144:195-223.
40. McInnes IB, Liew FY. Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol Today 1998;19:75-79 (Pubitemid 28097653)
41. McInnes IB, Liew FY, Gracie JA. Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Ther 2005;7:38-41.
42. Dinarello CA. Interleukin-18 and the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 2004;30:417-434 (Pubitemid 38692571)
43. Liew FY, Wei XQ, McInnes IB. Role of interleukin 18 in rheumatoid arthritis. Ann Rheum Dis 2003;62(Suppl 2):ii48-50. (Pubitemid 37323601)